The goal of this clinical trial is to assess if intravenous administration of linisol reduce the propofol consumption and the sides effects of sedation during gastroscopy in healthy patients (ASA 1 and 2 patients). Prior to propofol sedation, participants will receive either an intravenous bolus of linisol (1.5 mg/kg) = treated group or placebo = control group. After the gastroscopy, patients will be asked to complete a satisfaction questionnaire
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
total propofol dose in milligramme
Timeframe: procedure (from the beginning of propofol infusion until arrival of the gastroscope in the stomach)
total propofol dose in milligramme
Timeframe: Procedure (from the beginning of propofol infusion until endoscope removal)
propofol in site effet concentration in microgram per milliliter
Timeframe: procedure (from the beginning of propofol infusion until arrival of the gastroscope in the stomach)
propofol in site effet concentration in microgram per milliliter
Timeframe: Procedure (from the beginning of propofol infusion until endoscope removal)